What are your biggest launch excellence challenges today? ? Misaligned teams = missed opportunities ? Shrinking timelines ? More data isn’t the answer—better decisions are Sound familiar? In a recent webinar with Impatient Health, #pharma leaders shared how AI-driven insights are helping #MedicalAffairs and #Commercial teams refine strategies and maximize launch impact. ?? Access the on-demand replay & key takeaways: https://hubs.la/Q03bQXcd0
关于我们
As the integrated insights solution for pharmaceutical companies, Within3 solves the life science insight gap. Our insights management platform gathers, integrates, and analyzes insights better than any other platform on the market, reducing insight reporting from months to days and eliminating 90% of the workload. Companies use Within3 to drive strategy-impacting decisions up to 3x faster and ensure the customer's voice is heard across the enterprise. To learn more about the insights management platform or to request a demo, visit within3.com
- 网站
-
https://www.within3.com
Within3的外部链接
- 所属行业
- 软件开发
- 规模
- 51-200 人
- 总部
- Lakewood,Ohio
- 类型
- 私人持股
- 领域
- Digital Collaboration Solutions、Virtual Advisory Boards、Insights Management 、Insights Reporting和AI-supported Insights Analysis
地点
Within3员工
动态
-
Within3转发了
>NEXT 25' Dubrovnik - Session Announcement!> ?? Your Unfair Advantage: AI Market Intelligence In today’s pharma landscape,?data is power?– but only if you know how to use it. AI-driven market intelligence is revolutionizing decision-making, providing?real-time insights?that shape strategy and fuel innovation. Speaker: ?? Jason Smith?– CTO of AI & Analytics at?Within3 Join Jason as he delves into?how AI is transforming market intelligence, helping pharma companies gain?unparalleled competitive advantages?in an increasingly digital world. Be part of the conversation – Secure your ticket today! ???https://lnkd.in/dNEpnSdD #NEXTPharma #AI #MarketIntelligence #PharmaInnovation #NEXT25 #Dubrovnik
-
-
Spoiler alert: Open-source #AI tools aren’t built for #LifeSciences. They miss the mark on data privacy, compliance, and industry-specific needs, lacking the specificity and deep industry knowledge required for #pharma strategies. Explore the differences between AI models and discover what’s needed for industry-ready AI. ?? Read more: https://hubs.la/Q03by58R0
-
-
Discover how to harness data for smarter decisions, unlock the power of launch excellence, and decode AI jargon in our latest Insights Update. Plus, don’t miss our March 11 webinar with experts from BioNTech SE, Novartis, Sanofi, and Daiichi Sankyo on using real-time insights to fuel launch success. ?? Stay ahead—read now →
-
?? Final countdown! #MedicalAffairs and #commercial #pharma leaders, join Impatient Health, April Kelly, Luca Dezzani, Mark Montgomery, and Andreas Gerloff along with Within3 CEO Lance Hill tomorrow for practical strategies to overcome key launch challenges, including: ?? Insufficient Insights & Data ?? Shortened Launch Timelines ?? Limited Market Intelligence March 11, 2025 | 11:00 am EST | 3:00 pm GMT ?? Join the conversation: https://hubs.la/Q03bcG-K0 #Webinar #LaunchExcellence #LifeSciences
-
-
Within3转发了
Launches can soar to the heavens like a Starship rocket. Or they can rise slowly, fizzle and splutter back to earth like a damp firework on a cold day. The difference often depends on how we adapt to market conditions. When the rubber hits the road, can you steer past the obstacles? Good insights can help you see the right path, but only if you have a good plan in place to react to them. By implementing an insight strategy that is organised and directed, it’s possible to ensure continuing launch success from the offset. Register for my webinar tomorrow to see how: https://lnkd.in/embStf_6
-
-
Over a third of new therapies struggle to gain traction in their first year—despite extensive planning. The key to success? Launch excellence. Explore how #MedicalAffairs and #Commercial #pharma teams can leverage AI-driven insights to execute successful launches. Read more: https://hubs.la/Q039S11b0 #PharmaLaunch #LaunchExcellence #AI
-
-
Within3转发了
Think of the difference between a missile, and a guided missile. One is a point-and-shoot weapon that might hit the target, but… probably won’t. The other is, well, deadly. Unfortunately, pharma companies tend to launch new drugs using the bog-standard probably-going-to-land-in-a-field-of-sheep first option, while the new guided variety is already available to those who are in the know. By having real-time insights, you really can predict every obstacle and pivot and resonate far more quickly with customers. You just have to plan for it. Join my next webinar where Luca Dezzani Mark Montgomery April Kelly Andreas Gerloff Lance Hill will show you how it’s done. Jealous? Sign up to our upcoming webinar to learn how:? https://lnkd.in/embStf_6
-
-
How deep is your data lake? #Pharma companies collect massive amounts of data—but without the right strategy, it’s just noise and can become a liability. Within3's Jason Smith shares how to clean, connect, and extract real #insights from your #data for smarter decision-making. ?? Read more: https://hubs.la/Q039G-Qr0 #AI #MedicalAffairs #LifeSciences
-
-
?? Exciting News! We're heading to New Orleans for MAPS Americas 2025! Our team is excited to connect with Medical Affairs Professional Society (MAPS) members and share how real-time insights and AI-driven strategies are shaping the future of #pharma. ??Visit us at booth 121 to learn how we're helping #MedicalAffairs teams know more, move faster, and drive impact. Learn more here: https://hubs.la/Q039mxbn0 Tony Page Lauren Gioino Michael Kirby Vanessa Schildknecht, MsC Emelyn Ebeyer, MBA Meghan Carey #MAPSAmericas2025 #MAPSNOLA25 #MAPSEvents #JointheMovement
-